Literature DB >> 21877112

Attractive tools for systematic case accumulation.

Yasuo Oshima1, Arinobu Tojo2.   

Abstract

Mesh：

Year:  2011        PMID： 21877112     DOI： 10.1007/s12185-011-0893-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  Interstitial lung disease and gefitinib.

Authors:  Naoko Murashige; Tetsuya Tanimoto; Yasuo Oshima
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

2.  An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

Authors:  Andrea Clarke; Jonathan J Deeks; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia.

Authors:  Tetsuichi Yoshizato; Yasuhito Nannya; Yumiko Yoshiki; Fumihiko Nakamura; Yoichi Imai; Motoshi Ichikawa; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2011-02-24       Impact factor: 2.490
  3 in total
  2 in total

1.  Pulmonary alveolar hemorrhage possibly associated with lenalidomide use.

Authors:  Yasuo Oshima; Arinobu Tojo
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

2.  "Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.

Authors:  Yasuo Oshima; Koichiro Yuji; Arinobu Tojo
Journal:  Int J Hematol       Date:  2016-03-15       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.